Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
VISTARA BIOSCIENCE logo — Proteomic solutions for biomarker, target and drug candidate...

VISTARA BIOSCIENCE

Proteomic solutions for biomarker, target and drug candidate discovery and targeted degradation.

Founded 2016 United States Woodbridge, United States 4 employees Big Data, Biotechnology +1

General Information

Company Name VISTARA BIOSCIENCE
Founded Year 2016
Location United States Woodbridge, United States +1
Employees 4
Industries Big Data, Biotechnology, IT
Social

Get notified when VISTARA BIOSCIENCE moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About VISTARA BIOSCIENCE

Vistara Bioscience is a biotechnology startup that focuses on developing proteomics tools for drug discovery research, particularly in the field of Targeted Protein Degradation (TPD) and other therapeutic modalities. The company's TRIFECTA strategy involves a combination of ubiquitomics, compound screening, and protein disruption processes with clinical applications in Oncology, Inflammation, and Neurodegeneration disease areas. Recent clinical outcomes in TPD have highlighted the complexity involved in finding effective solutions, emphasizing the need for detailed information about the clinical target's proteostasis mechanisms. Vistara Bioscience's global ubiquitome scanning technologies aim to identify similarities and differences between samples, providing contextual information about target protein's proteostasis, including protein networks, accessory factors, pathway components, and compound-induced changes of proteins in collaboration with proteins of clinical interest. By integrating their processes, design tools, and informatics, Vistara Bioscience aims to develop tailored TPD solutions. Additionally, the identified networks serve as biomarker panels to guide the drug discovery process and may suggest combinatorial targets or new ones. Founded in 2016, Vistara Bioscience operates within the Big Data, Biotechnology, and IT industries. As of now, there is no available information about the company's last investment or investors.

Taxonomy: Proteomics, Biomarker Discovery, Targeted Protein Degradation, TRIFECTA Strategy, Ubiquitomics, Drug Discovery, Therapeutic Modalities, Oncology, Inflammation, Neurodegeneration, Pharma Partnerships, Biotech Partnerships, Candidate Profiling, Molecular Phenotyping, Infectious Diseases

No funding data available for VISTARA BIOSCIENCE yet.

Get notified when VISTARA BIOSCIENCE raises funding

VISTARA BIOSCIENCE Alternatives & Competitors

VISTARA BIOSCIENCE vs
Kemp Proteins
Kemp Proteins United States

Protein Problem-Solvers: Quality Expressed

32 employees
VISTARA BIOSCIENCE vs
TRIANA Biomedicines
TRIANA Biomedicines

A venture-backed biopharmaceutical company dedicated to discovering and developing novel therapeutic...

VISTARA BIOSCIENCE vs
Sanoosa Pty. Ltd.
Sanoosa Pty. Ltd. Australia

We Computerize Drug Discovery

1 employees

FAQ About VISTARA BIOSCIENCE

Proteomic solutions for biomarker, target and drug candidate discovery and targeted degradation.
VISTARA BIOSCIENCE was founded in 2016.
VISTARA BIOSCIENCE is headquartered in Woodbridge, United States.
VISTARA BIOSCIENCE operates in the following industries: Big Data, Biotechnology, IT.
VISTARA BIOSCIENCE has approximately 4 employees.
Top alternatives and competitors to VISTARA BIOSCIENCE include Kemp Proteins, TRIANA Biomedicines, Sanoosa Pty. Ltd., Plexium, AnHorn Medicines. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
VISTARA BIOSCIENCE and Kemp Proteins are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors VISTARA BIOSCIENCE and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy